Adrian Folkes
Impact in
- Toxicology top 5%
-
- Drug Transport and Resistance Mechanisms
Papers in
-
- Cancer therapeutics and mechanisms 4
- Signaling Pathways in Disease 3
- Oncology 5
- Drug Transport and Resistance Mechanisms 3
- Cancer Treatment and Pharmacology 2
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Peter Charlton (6 shared papers)Wendy Dangerfield (2 shared papers)Sukhjit Sohal (4 shared papers)Richard Faint (4 shared papers)Philip J. Ashworth (1 shared paper)Hamish Ryder (1 shared paper)Michael W. Roe (1 shared paper)Prakash Mistry (3 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Medicinal Chemistry (2 papers)Cancer Research (2 papers)Blood Coagulation & Fibrinolysis (1 paper)Fibrinolysis & proteolysis (1 paper)
- Partner nations
- United KingdomUnited StatesNew Zealand
In The Last Decade
Adrian Folkes
11 papers receiving 416 citations
Peers
Comparison fields: 5 of 58
- Toxicology 46
- Oncology 161
- Organic Chemistry 163
- Cancer Research 70
- Hematology 48
Countries citing papers authored by Adrian Folkes
This map shows the geographic impact of Adrian Folkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Folkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Folkes more than expected).
Fields of papers citing papers by Adrian Folkes
This network shows the impact of papers produced by Adrian Folkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Folkes. The network helps show where Adrian Folkes may publish in the future.
Co-authors
The 25 scholars most cited alongside Adrian Folkes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 136 | |
| 2 | 2002 | 116 | |
| 3 | 2004 | 69 | |
| 4 | 2001 | 47 | |
| 5 | 2002 | 29 | |
| 6 | 1997 | 24 | |
| 7 | ONT-093 (Ontogen). | 2002 | 7 |
| 8 | The discovery of GDC-0941: A potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer | 2008 | 5 |
| 9 | The use of raltitrexed (tomudex) in a patient with 5-fluorouracil induced myocardial ischaemia. | 1999 | 4 |
| 10 | 1996 | 1 | |
| 11 | Pharmacological properties of the PI3 kinase (PI3K) inhibitors PI-540 and PI-620 | 2008 | 1 |
About Adrian Folkes
Adrian Folkes is a scholar working on Molecular Biology, Oncology, Hematology, Cancer Research and Organic Chemistry, having authored 11 papers that have together received 439 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Protease and Inhibitor Mechanisms (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Signaling Pathways in Disease (3 papers), Cancer Treatment and Pharmacology (2 papers), Synthesis and biological activity (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Toxicology (46 citations), Oncology (161 citations), Organic Chemistry (163 citations), Cancer Research (70 citations) and Hematology (48 citations). Adrian Folkes has collaborated with scholars based in United Kingdom, United States and New Zealand. Frequent co-authors include Peter Charlton, Wendy Dangerfield, Sukhjit Sohal, Richard Faint, Philip J. Ashworth, Hamish Ryder, Michael W. Roe, Prakash Mistry, Shouming Wang and Stephen P. Wren. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Cancer Research, Blood Coagulation & Fibrinolysis and Fibrinolysis & proteolysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.